Gregory S. Martini - 27 Jan 2025 Form 3 Insider Report for IRONWOOD PHARMACEUTICALS INC (IRWD)

Role
Chief Financial Officer
Signature
/s/ Brian Tessler, Attorney-in-Fact
Issuer symbol
IRWD
Transactions as of
27 Jan 2025
Net transactions value
$0
Form type
3
Filing time
29 Jan 2025, 17:29:23 UTC
Next filing
12 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding IRWD Class A Common Stock 84,751 27 Jan 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IRWD Employee Stock Options (Right to Buy) 27 Jan 2025 Class A Common Stock 3,307 $16.90 Direct F2
holding IRWD Employee Stock Options (Right to Buy) 27 Jan 2025 Class A Common Stock 1,587 $12.95 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option, granted as an annual performance award, is presently exercisable in full.
F2 This option, granted as a new hire award, is presently exercisable in full.

Remarks:

Exhibit 24 - Power of Attorney